<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="33%"></col>
<col width="21%"></col>
<col width="46%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">Concomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">Effect on Concentration of Lamotrigine or Concomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">Clinical Comment</content>
</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>Decreased lamotrigine concentrations approximately 50%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ levonorgestrel</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Carbamazepine and carbamazepine epoxide</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>? carbamazepine epoxide</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>May increase carbamazepine epoxide levels.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Lopinavir/ritonavir</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased lamotrigine concentration approximately 50%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Atazanavir/ritonavir</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased lamotrigine AUC approximately 32%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Phenobarbital/primidone</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Phenytoin</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Rifampin</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased lamotrigine AUC approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Valproate</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>↑ lamotrigine</paragraph>
</td>
<td stylecode="Rrule " valign="top">
<paragraph>Increased lamotrigine concentrations slightly more than 2-fold.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>? valproate</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>There are conflicting study results regarding effect of lamotrigine on valproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change in valproate concentrations in controlled clinical trials in patients with epilepsy.</paragraph>
</td>
</tr>
</tbody>
</table>